Double-lumen infusion catheter including: a shaft having proximal section, distal section, and intermediate section therebetween; first and second lumens extending along a length of the shaft and having arc shaped wall therebetween; and an inflatable member provided distally to intermediate section, and over the distal section. First lumen has cross section larger than cross section of second lumen and is configured to receive a guidewire therethrough and allow fluid flow via an unobstructed portion of first lumen. Unobstructed portion is formed along guidewire outer surface, between guidewire outer surface and inner wall of first lumen, and extends from an inlet at proximal end of intermediate section to an outlet at distal end of intermediate section. First lumen is narrowed to approximate a first diameter in shaft proximal and distal sections, and is widened to approximate a second diameter greater than first diameter in the shaft intermediate section.

A delivery assembly includes a console including a vial containment region and a vial engagement mechanism extending from the console within the vial containment region. The engagement mechanism is configured to engage a vial assembly. The delivery assembly further includes a sled assembly removably coupled to the console at the vial containment region and a safety shield removably coupled to the console over the vial containment region such that the vial engagement mechanism and the sled assembly are encapsulated within the safety shield when the safety shield is coupled thereto. The sled assembly, the vial assembly, and the safety shield are configured to inhibit radioactive emissions from within the vial containment region.

Left atrial appendage (LAA) occlusion device including a membrane, a plurality of fixation splines and a deployment hub, the plurality of fixation splines for affixing the LAA occlusion device to an ostium of the LAA, the deployment hub being positioned in the membrane, the deployment hub including a threaded aperture and a one-way valve, for enabling a toxin to be entered into the LAA through the deployment hub.

The present invention relates to a an anti-thrombotic medical instrument and catheter medical instrument comprising: base with a port for connection to an infusion set; a catheter extending from the base, and comprises a main body of tubular configuration. a plurality of lateral conduits distributed along the length of the catheter; an elastomeric cover over each lateral conduit, said elastomeric cover opens with a fluid flow inside the catheter and closes when the fluid flow stops. Said lateral conduits have an angle in the range of 15° to 60° to the longitudinal axis of the catheter.

An innovative medical device that permits rapid, minimally invasive restoration of blood flow across a vascular blockage. A method employing said device, allowing for lysis or removal of said blockage. Said device creates a temporary bypass using longitudinal structure configured for insertion into the blood vessel and adapted to deliver a side hole to a target area. The side hole defines a distal first segment and a proximal second segment with a lumen to allow blood flow therethrough to the distal end hole. In an alternate embodiment, a slidable outer sheath can cover the side hole to permit reversal of blood flow from the distal end hole to a proximal end hole located outside a patient's body by means of an aspiration controller. Alternate embodiments include an optional anchoring balloon, a macerating stent or wires, perforations for fluid delivery, and a backflow valve.

An apparatus for performing a medical procedure and, in particular, an aortic valvuloplasty, in a vessel for transmitting a flow of fluid. The apparatus comprises a shaft, an inflatable perfusion balloon supported by the shaft and including an internal passage for permitting the fluid flow in the vessel while the perfusion balloon is in an inflated condition, and a valve for controlling the fluid flow within the passage. The valve may be connected to the shaft, or may comprise an elongated tube partially connected to the balloon. The balloon may comprise a plurality of cells in a single cross-section, each cell including a neck, and the valve may be positioned in a space between the shaft and the necks for controlling the fluid flow within the passage. A connector may also be provided to control the position of the valve.

An indwelling valve actuated urinary catheter has an inner catheter having an inlet port configured on a distal end and for locating within the bladder and a sheath that extends over the inner catheter to produce a valve. The sheath extends over the inlet port when the valve is in a closed position and manipulation of a valve actuator on the proximal end, located within the penis, opens the valve. A bladder plug configured on the distal end of the inner catheter may form a seal between the catheter sheath and the inner catheter. The valve actuator may comprise a proximal nodule and a distal nodule that are configured within the urethra along the penis. Manual manipulation of the valve actuator through the penis, such as by pinching the penis, moves the proximal and distal nodules with respect to each other to open or close the valve.

A dual suction tube is provided that includes a lower section, an upper section, and a transitional zone. The lower section includes at least one eyelet disposed at a distal end of the lower section. The upper section includes at least one port configured to be connected to a vacuum source. The transitional zone is between the lower section and the upper section, and has a first cross-sectional area at a proximal end of the transitional zone and a second cross-sectional area at a distal end of the transitional zone. The first cross-sectional area is greater than the second cross-sectional area.

A device can be coupled to a foley catheter inserted into the bladder of a patient, where the foley catheter includes a urine passage through which urine can be drained from the bladder. The device includes a pressure sensor that is connected to a urine outlet of the urine passage and configured to measure a pressure value of the urine being drained through the urine outlet, a processor connected to the pressure sensor and configured to determine whether the foley catheter can be removed by comparing the pressure value and a predetermined threshold value, and a display unit connected to the processor and displaying whether the foley catheter can be removed according to the control of the processor.

A catheter device for performing a cardiac sympathetic denervation intervention includes an ablation device for applying an ablation action. The ablation device has an expansion member that is expandable from a compressed delivery state to an expanded ablation state. The expansion member includes an inner lumen defining a blood flow passage through the ablation device in the expanded ablation state of the expansion member in an antegrade flow direction (F). The catheter device is configured for introduction into the aorta to perform a cardiac sympathetic denervation intervention at an ablation site within the aorta. The expansion member is configured to abut, in the expanded ablation state, an aortic wall section (W) and carries an ablation arrangement for applying ablation action at the ablation site.